Puma Biotechnology (PBYI):
The company's earnings for share shows growth of 5.20% for the current year. The company's EPS growth rate for the past five years was -18.10%. Stock for several years. The company's earnings will be a direct relationship to the price of the company's stock. EPS growth quarter over quarter stands at 82.00% and Sales growth quarter over quarter at 926.20%.
Puma Biotechnology (PBYI) observed a change of -2.53% pushing the price on the $ 23.52 per share in recent trading session ended on Tuesday. The latest trading activity shows that the stock price is 33.64% off from its 52-week low and traded with the move -77.87% from the high 52-week period. The Company kept 32.96M Floating Shares and holds 39.05M shares outstanding.
Share on Twitter Share to Twitter Share to Facebook Share to Facebook Share to Facebook Share to Twitter Share to Facebook Analyses consensus rating score stands at 2.8. Analysts is $ 39 for the next one year period.
As a short look on profitability, the firm profit margin which was recorded -72.90%, and operating margin was noted at -69.30%. The company maintained at Gross Margin of 86.00%. The Institutional ownership of the firm is 95.80% while Insiders ownership is 11.30%. Company has kept return on investment (ROI) at -287.20% over the previous 12 months and has been able to maintain return on assets (ROA) at -74.10% for the last twelve months. Return on equity (ROE) recorded at -301.50%.
Puma Biotechnology (PBYI) stock recent traded volume stands with 551470 shares as compared to its average volume of 1310.7K shares. The related volume observed at 0.42.
Volume can help determine the health of an existing trend. A healthy up-trend should have higher volume on the upward legs of the trend, and lower volume on the downward (corrective) legs. A healthy downtrend usually has higher volume on the downward legs of the trend and lower volume on the upward (corrective) legs.
Its debt ratio with its assets (cash, marketable securities, inventory, accounts receivable). As such, a current ratio can be used as a rough estimate of a company's financial health. The quick ratio of a short-term financial liability with quick assets (cash and cash equivalents, short-term marketable securities, and accounts receivable). The higher the ratio, the more financially secure the company is in the short term. A common law of thumb is that companies are able to meet their short-term liabilities.
A long term debt / equity shows a value of 2.64 with a total debt / equity of 2.64. It gives the investors the idea on the company's financial leverage, measured by apportioning total liabilities by its stockholders equity. It also illustrates how much debt is used in equity.
Moving on a daily basis to the day-to-day price fluctuations, or noise. By identifying trends, moving trades to make those trends work in their favor and increasing the number of winning trades. Will change with the price of the period of a moving average. However, it is more likely to provide less reliable signals compared to those provided by a longer-term moving average. Will change with the price of the longer period. However, the signals it provides are more reliable.
Puma Biotechnology (PBYI) stock moved up 1.60% in contrast to its 20 days moving average displaying short-term positive movement of stock. It shifted -27.87% below its 50-day simple moving average. This is showing medium-term pessimistic trend based on SMA 50. The stock price went underground -53.25% from its 200-day simple moving average identifying long-term downward trend.
Larry Spivey – Category – Business
Larry Spivey also covers the business news across all market sectors. He also has an enormous knowledge of the stock market. He holds an MBA degree from the University of Florida. He has been more than 10 years of experience in writing financial and market news. Webmaster, software engineer and product manager. He currently covers Business news section.
